Mumps vaccine effectiveness in primary schools and households, the Netherlands, 2008
- PMID: 22381073
- DOI: 10.1016/j.vaccine.2012.02.035
Mumps vaccine effectiveness in primary schools and households, the Netherlands, 2008
Abstract
To estimate the mumps vaccine effectiveness (VE) during a large genotype D mumps outbreak, we conducted a cross-sectional study in eight primary schools and associated households in the Netherlands. Questionnaires were used to collect information on the occurrence of mumps. Multivariate analyses were used to estimate VE. Among schoolchildren we estimated the VE against mumps. Among household contacts where the schoolchild was the index case we estimated the VE against mumps and against mumps infectiousness. In total 1175 children and 2281 household contacts participated in the study. The mumps attack rate among schoolchildren was 17%. The mumps VE in schoolchildren was 92% [95% confidence interval (CI) 83-96%] and 93% [85-97%] for one and two doses of the measles, mumps, rubella (MMR) vaccine, respectively. The adjusted mumps VE among household contacts was 67% [65-95%] and 11% [-4 to 88%] against mumps and mumps infectiousness, respectively. Our study indicates that the mumps component of the MMR vaccine offered adequate protection against mumps among schoolchildren. The relatively low VE among household contacts is of concern.
Copyright © 2012 Elsevier Ltd. All rights reserved.
Similar articles
-
Mumps vaccine effectiveness and risk factors for disease in households during an outbreak in New York City.Vaccine. 2014 Jan 9;32(3):369-74. doi: 10.1016/j.vaccine.2013.11.021. Epub 2013 Nov 16. Vaccine. 2014. PMID: 24252695
-
Mumps vaccine effectiveness in highly immunized populations.Vaccine. 2010 Apr 30;28(20):3567-70. doi: 10.1016/j.vaccine.2010.02.107. Epub 2010 Mar 10. Vaccine. 2010. PMID: 20226249
-
Assessment of mumps-containing vaccine effectiveness during an outbreak: Importance to introduce the 2-dose schedule for China.Hum Vaccin Immunother. 2018 Jun 3;14(6):1392-1397. doi: 10.1080/21645515.2018.1428508. Epub 2018 Feb 15. Hum Vaccin Immunother. 2018. PMID: 29377772 Free PMC article.
-
[Mumps makes a comeback].Ned Tijdschr Geneeskd. 2012;156(43):A5187. Ned Tijdschr Geneeskd. 2012. PMID: 23095482 Review. Dutch.
-
[Sero-epidemiologic study of measles, rubella and mumps in the infantile population of Salamanca].An Esp Pediatr. 1992 Apr;36(4):293-7. An Esp Pediatr. 1992. PMID: 1605414 Review. Spanish.
Cited by
-
Vaccines for measles, mumps, rubella, and varicella in children.Cochrane Database Syst Rev. 2020 Apr 20;4(4):CD004407. doi: 10.1002/14651858.CD004407.pub4. Cochrane Database Syst Rev. 2020. Update in: Cochrane Database Syst Rev. 2021 Nov 22;11:CD004407. doi: 10.1002/14651858.CD004407.pub5. PMID: 32309885 Free PMC article. Updated.
-
Vaccines for measles, mumps, rubella, and varicella in children.Cochrane Database Syst Rev. 2021 Nov 22;11(11):CD004407. doi: 10.1002/14651858.CD004407.pub5. Cochrane Database Syst Rev. 2021. PMID: 34806766 Free PMC article.
-
Epidemic of mumps among vaccinated persons, The Netherlands, 2009-2012.Emerg Infect Dis. 2014 Apr;20(4):643-8. doi: 10.3201/eid2004.131681. Emerg Infect Dis. 2014. PMID: 24655811 Free PMC article.
-
Seroepidemiology of mumps in the general population of Jiangsu province, China after introduction of a one-dose measles-mumps-rubella vaccine.Sci Rep. 2015 Oct 1;5:14660. doi: 10.1038/srep14660. Sci Rep. 2015. PMID: 26423223 Free PMC article.
-
Vaccine effectiveness against SARS-CoV-2 transmission and infections among household and other close contacts of confirmed cases, the Netherlands, February to May 2021.Euro Surveill. 2021 Aug;26(31):2100640. doi: 10.2807/1560-7917.ES.2021.26.31.2100640. Euro Surveill. 2021. PMID: 34355689 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical